A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer
NOT ENROLLING
Trial ID:
NCT03661320 Protocol # :
18-649
Phase
III
Disease Sites
Urinary Bladder
Principal Investigator
McGregor, Bradley, A.
Site Investigator
Bubley, Glenn
Site Research Nurses
Aspinwall, Sheridan
Bretta, Katherine, v.
Carey, Margaret, M.
Creaton, Eileen
Gundy, Kathryn, E.
Healy, Erin, C.
Kabarame, Liliane
Katica, Dean
Kelleher, Kaitlin
Lagerstedt, Elizabeth
Leisner, Claire
Mingrino, Sage
Pace, Amanda
Polinski, Karen
Porter, Kathryn
Prisby, Judith
Theodore, Catherine
Walsh, Meghara
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #18-649
18-649